Celltrion, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-74.2% vs price
Base Case (Median)
-63.7% vs price
Bull Case (75th pct.)
-36.3% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $34493.73 | -80.1% | High (40%) |
| PE Comparable | $123590.54 | -28.6% | Medium (25%) |
| Growth Trajectory DCF | $279988.62 | 61.8% | Medium (20%) |
| Graham Number | $96723.76 | -44.1% | Medium (40%) |
| EV/EBITDA | $62870.65 | -63.7% | Medium (20%) |
| EV/FCF | $44006.24 | -74.6% | Medium (20%) |
| Earnings Power Value | $45108.46 | -73.9% | Medium (50%) |
Based on 7 out of 8 methods, 068270.KS appears overvalued at the current price of $173000.00. The base case fair value of $62870.65 implies 63.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.